Enhancer ID: | E_02_0483 |
Species: | human |
Position : | chr5:88714837-88716837 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Pulmonary arterial hypertension |
Pubmed ID: | 30106596 |
Enhancer experiment: | Flow cytometry, immunofluorescence light staining |
Enhancer experiment description: | MEF2 (myocyte enhancer factor 2) is a transcription factor that regulates multiple genes that are important during cardiovascular development and for vascular homeostasis (1), with MEF2C known to play a crucial role in regulating endothelial integrity, survival, and angiogenesis (2). Some of the results of these studies have been previously reported in the form of an abstract (5). Methods To investigate the role of endothelial MEF2 function in the pathogenesis of PH, we generated adult mice with inducible, endothelial-specific deletion of the Mef2c allele, using a tamoxifen-responsive Cdh5 promoter driven Cre recombinase crossed to mice with Mef2cfl/fl alleles (henceforth called Mef2cECKO mice) (6, 7). |
Target gene : | MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | MEF2 (myocyte enhancer factor 2) is a transcription factor that regulates multiple genes that are important during cardiovascular development and for vascular homeostasis (1), with MEF2C known to play a crucial role in regulating endothelial integrity, survival, and angiogenesis (2). Some of the results of these studies have been previously reported in the form of an abstract (5). Methods To investigate the role of endothelial MEF2 function in the pathogenesis of PH, we generated adult mice with inducible, endothelial-specific deletion of the Mef2c allele, using a tamoxifen-responsive Cdh5 promoter driven Cre recombinase crossed to mice with Mef2cfl/fl alleles (henceforth called Mef2cECKO mice) (6, 7). |
TF name : | -- |
TF experiment: | ?????,??????? |
TF experiment description: | MEF2 (myocyte enhancer factor 2) is a transcription factor that regulates multiple genes that are important during cardiovascular development and for vascular homeostasis (1), with MEF2C known to play a crucial role in regulating endothelial integrity, survival, and angiogenesis (2). Some of the results of these studies have been previously reported in the form of an abstract (5). Methods To investigate the role of endothelial MEF2 function in the pathogenesis of PH, we generated adult mice with inducible, endothelial-specific deletion of the Mef2c allele, using a tamoxifen-responsive Cdh5 promoter driven Cre recombinase crossed to mice with Mef2cfl/fl alleles (henceforth called Mef2cECKO mice) (6, 7). |
Enhancer function : | MEF2 (myocyte enhancer factor 2) is a transcription factor that regulates multiple genes that are important during cardiovascular development and for vascular homeostasis (1), with MEF2C known to play a crucial role in regulating endothelial integrity, survival, and angiogenesis (2). Some of the results of these studies have been previously reported in the form of an abstract (5). Methods To investigate the role of endothelial MEF2 function in the pathogenesis of PH, we generated adult mice with inducible, endothelial-specific deletion of the Mef2c allele, using a tamoxifen-responsive Cdh5 promoter driven Cre recombinase crossed to mice with Mef2cfl/fl alleles (henceforth called Mef2cECKO mice) (6, 7). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
MEF2 (myocyte enhancer factor 2) is a transcription factor that regulates multiple genes that are important during cardiovascular development and for vascular homeostasis (1), with MEF2C known to play a crucial role in regulating endothelial integrity, survival, and angiogenesis (2). Some of the results of these studies have been previously reported in the form of an abstract (5). Methods To investigate the role of endothelial MEF2 function in the pathogenesis of PH, we generated adult mice with inducible, endothelial-specific deletion of the Mef2c allele, using a tamoxifen-responsive Cdh5 promoter driven Cre recombinase crossed to mice with Mef2cfl/fl alleles (henceforth called Mef2cECKO mice) (6, 7). |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|